Hyperglycemia, a neglected factor during cancer progression

186Citations
Citations of this article
189Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent evidence from large cohort studies suggests that there exists a higher cancer incidence in people with type 2 diabetes (DM2). However, to date, the potential reasons for this association remain unclear. Hyperglycemia, the most important feature of diabetes, may be responsible for the excess glucose supply for these glucose-hungry cells, and it contributes to apoptosis resistance, oncogenesis, and tumor cell resistance to chemotherapy. Considering associations between diabetes and malignancies, the effect of hyperglycemia on cancer progression in cancer patients with abnormal blood glucose should not be neglected. In this paper, we describe the role that hyperglycemia plays in cancer progression and treatment and illustrate that hyperglycemia may contribute to a more malignant phenotype of cancer cells and lead to drug resistance. Therefore, controlling hyperglycemia may have important therapeutic implications in cancer patients. © 2014 Wanxing Duan et al.

Cite

CITATION STYLE

APA

Duan, W., Shen, X., Lei, J., Xu, Q., Yu, Y., Li, R., … Ma, Q. (2014). Hyperglycemia, a neglected factor during cancer progression. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/461917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free